Benitec Biopharma Limited Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending June 30, 2022 was 36.85% (a -273.17% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -85.78%
  • Annual Research and Development (R&D) Expenses Growth for 2022 was 60.57% (a Infinity% increase from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2021 was 0.0% (a -100.0% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2021 was 133.92% (a Infinity% increase from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending June 30, 2022 was 60.57% (a -21.68% decrease compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -64.22% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
60.57% 77.34% 180.64% 169.27%
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of Benitec Biopharma Limited

Most recent Research and Development (R&D) Expenses Growthof BNTC including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of Benitec Biopharma Limited

Benitec Biopharma Limited Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 36.85% -21.28% 60.57%
2021 169.35% 259.17% 97.61% 242.61% 0.0%
2020 94.99% 82.98% 5.74% -57.81% 0.0%
2019 -48.72% -45.35% 0.0%
2018 -30.66%
2017 -5.43% -0.03%
2016 137.03% 0.1%
2015 51.11%
2014 162.43%
2013 -61.89%

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology